RNASeq analysis of NB1691 neuroblastoma cells treated with MDM2-p53 inhibitor RG7388 alone and in combination with temozolomide
Ontology highlight
ABSTRACT: RNASeq analysis of NB1691 neuroblastoma cells treated with MDM2-p53 inhibitor RG7388 alone and in combination with temozolomide
PROVIDER: PRJNA414128 | ENA |
REPOSITORIES: ENA
ACCESS DATA